News Database — USIJ

Posts by USIJ

USIJ Applauds SJC for Passage of PREVAIL Act

USIJ Applauds SJC for Passage of PREVAIL Act

USIJNovember 21, 2024

USIJ & MDMA Submit Letter of Support for PERA, PREVAIL, & IDEA

USIJNovember 13, 2024

USIJ & MDMA Letter in Support of PERA, PREVAIL & IDEA

USIJSeptember 16, 2024

USIJ Statement of Support of House PERA

USIJSeptember 6, 2024

USIJ Applauds Introduction of the RESTORE Act

USIJJuly 30, 2024

USIJ Response to RFC re Terminal Disclaimer Proposal

USIJJuly 10, 2024

USIJ Comments on PTO Docket No. P 2023-0048 re: Exercise of Discretion

USIJJune 19, 2024

USIJ Comments on PTO Fee Setting

USIJJune 4, 2024

USIJ Letter to Chairman Durbin & Ranking Member Graham re: SJC Drug Pricing Hearing

USIJMay 21, 2024

MDMA & USIJ Letter in Support of PREVAIL and PERA

USIJApril 10, 2024

USIJ Files Amicus Brief on Google v. Sonos

USIJFebruary 21, 2024

USIJ Reponse to NIST Bayh Dole Guidance RFI

USIJFebruary 6, 2024

USIJ Request for NIST Extension

USIJJanuary 5, 2024

USIJ Response to March-In Decision

USIJDecember 7, 2023

Why Teaching Youth About Intellectual Property Principles Is Essential to Civilization's Advancement

USIJNovember 17, 2023

USIJ Letter in Support of PREVAIL Act

USIJ Letter in Support of PREVAIL Act

USIJNovember 15, 2023

USIJ Statement on USITC Report

USIJOctober 18, 2023

USIJ Statement for NIH Workshop

USIJJuly 27, 2023

USIJ Response to RFC on Track Three Pilot Program

USIJJuly 26, 2023

USIJ Applauds House version of PREVAIL

USIJJune 28, 2023